197 related articles for article (PubMed ID: 9426686)
1. Allelotype analysis of hepatocellular carcinoma.
Piao Z; Park C; Park JH; Kim H
Int J Cancer; 1998 Jan; 75(1):29-33. PubMed ID: 9426686
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors.
Okabe H; Ikai I; Matsuo K; Satoh S; Momoi H; Kamikawa T; Katsura N; Nishitai R; Takeyama O; Fukumoto M; Yamaoka Y
Hepatology; 2000 May; 31(5):1073-9. PubMed ID: 10796882
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of genetic changes during development and progression of hepatocellular carcinoma: loss of heterozygosity of chromosome arm 1p occurs at an early stage of hepatocarcinogenesis.
Kuroki T; Fujiwara Y; Tsuchiya E; Nakamori S; Imaoka S; Kanematsu T; Nakamura Y
Genes Chromosomes Cancer; 1995 Jul; 13(3):163-7. PubMed ID: 7669735
[TBL] [Abstract][Full Text] [Related]
4. Assessment of chromosomal losses and gains in hepatocellular carcinoma.
Chang J; Kim NG; Piao Z; Park C; Park KS; Paik YK; Lee WJ; Kim BR; Kim H
Cancer Lett; 2002 Aug; 182(2):193-202. PubMed ID: 12048165
[TBL] [Abstract][Full Text] [Related]
5. Genetic changes and histopathological grades in human hepatocellular carcinomas.
Konishi M; Kikuchi-Yanoshita R; Tanaka K; Sato C; Tsuruta K; Maeda Y; Koike M; Tanaka S; Nakamura Y; Hattori N
Jpn J Cancer Res; 1993 Aug; 84(8):893-9. PubMed ID: 8407553
[TBL] [Abstract][Full Text] [Related]
6. Clonality analysis of multiple hepatocellular carcinomas by loss of heterozygosity pattern determined by chromosomes 16q and 13q.
Lin YW; Lee HS; Chen CH; Huang GT; Lee PH; Sheu JC
J Gastroenterol Hepatol; 2005 Apr; 20(4):536-46. PubMed ID: 15836701
[TBL] [Abstract][Full Text] [Related]
7. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide analyses on loss of heterozygosity in hepatocellular carcinoma in Southern China.
Li SP; Wang HY; Li JQ; Zhang CQ; Feng QS; Huang P; Yu XJ; Huang LX; Liang QW; Zeng YX
J Hepatol; 2001 Jun; 34(6):840-9. PubMed ID: 11451167
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal instability and human hepatocarcinogenesis.
Nishida N; Nishimura T; Ito T; Komeda T; Fukuda Y; Nakao K
Histol Histopathol; 2003 Jul; 18(3):897-909. PubMed ID: 12792902
[TBL] [Abstract][Full Text] [Related]
10. PTEN / MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas.
Fujiwara Y; Hoon DS; Yamada T; Umeshita K; Gotoh M; Sakon M; Nishisho I; Monden M
Jpn J Cancer Res; 2000 Mar; 91(3):287-92. PubMed ID: 10760687
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan.
Sheu JC; Lin YW; Chou HC; Huang GT; Lee HS; Lin YH; Huang SY; Chen CH; Wang JT; Lee PH; Lin JT; Lu FJ; Chen DS
Br J Cancer; 1999 May; 80(3-4):468-76. PubMed ID: 10408855
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic and molecular genetic alterations in hepatocellular carcinoma.
Lau SH; Guan XY
Acta Pharmacol Sin; 2005 Jun; 26(6):659-65. PubMed ID: 15916730
[TBL] [Abstract][Full Text] [Related]
13. Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis.
Midorikawa Y; Yamamoto S; Tsuji S; Kamimura N; Ishikawa S; Igarashi H; Makuuchi M; Kokudo N; Sugimura H; Aburatani H
Hepatology; 2009 Feb; 49(2):513-22. PubMed ID: 19105209
[TBL] [Abstract][Full Text] [Related]
14. Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade--results of an explorative CGH meta-analysis.
Moinzadeh P; Breuhahn K; Stützer H; Schirmacher P
Br J Cancer; 2005 Mar; 92(5):935-41. PubMed ID: 15756261
[TBL] [Abstract][Full Text] [Related]
15. [Genome-wide loss of heterozygosity analyses in primary hepatocellular carcinoma].
Li S; Wang H; Zhang C
Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):577-81. PubMed ID: 11798820
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive allelotyping of human hepatocellular carcinoma.
Nagai H; Pineau P; Tiollais P; Buendia MA; Dejean A
Oncogene; 1997 Jun; 14(24):2927-33. PubMed ID: 9205099
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide loss of heterozygosity analysis of chemically induced rat hepatocellular carcinomas reveals elevated frequency of allelic imbalances on chromosomes 1, 6, 8, 11, 15, 17, and 20.
Teeguarden JG; Newton MA; Dragan YP; Pitot HC
Mol Carcinog; 2000 May; 28(1):51-61. PubMed ID: 10820488
[TBL] [Abstract][Full Text] [Related]
18. [Frequent loss of heterozygosity on chromosome 4 in human hepatocellular carcinoma].
Li X; Ding M; Lai B
Zhonghua Yi Xue Za Zhi; 2001 Jan; 81(1):37-40. PubMed ID: 11798850
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity of chromosome 8p and 11p in the dysplastic nodule and hepatocellular carcinoma.
Kahng YS; Lee YS; Kim BK; Park WS; Lee JY; Kang CS
J Gastroenterol Hepatol; 2003 Apr; 18(4):430-6. PubMed ID: 12653892
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma.
Pang JZ; Qin LX; Ren N; Hei ZY; Ye QH; Jia WD; Sun BS; Lin GL; Liu DY; Liu YK; Tang ZY
Clin Cancer Res; 2007 Dec; 13(24):7363-9. PubMed ID: 18094418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]